Harvard Apparatus Regenerative Technology, Inc. 8-K

What Happened

• Harvard Apparatus Regenerative Technology, Inc. announced it entered into Securities Purchase Agreements effective December 30, 2025, under which certain investors agreed to purchase an aggregate of 411,765 shares of the Company’s common stock.
• The aggregate purchase price for the private placement is approximately $0.7 million, at a purchase price of $1.70 per share. The company filed the transaction on Form 8‑K on January 6, 2026.

Key Details

• Shares sold: 411,765 common shares.
• Price: $1.70 per share; aggregate proceeds ≈ $0.7 million.
• Agreements effective date: December 30, 2025; filing date: January 6, 2026.
• The sale was a private, unregistered placement under Securities Purchase Agreements; the form of Purchase Agreement is filed as Exhibit 10.1.
• The Purchase Agreements include customary representations, warranties and covenants that are for the parties’ benefit and may not reflect complete facts about the company.

Why It Matters

• The transaction brings roughly $0.7M in cash to the company, which may support operations, development or near‑term liquidity needs.
• Because the shares were sold in a private placement and not a public offering, this may dilute existing shareholders’ ownership depending on company share count and any future financings.
• Investors should review the filed Purchase Agreement (Exhibit 10.1) and monitor future disclosures for use of proceeds or additional financing details.